Literature DB >> 26279999

Nonthyroidal Illness Syndrome in Cardiac Illness Involves Elevated Concentrations of 3,5-Diiodothyronine and Correlates with Atrial Remodeling.

Johannes W Dietrich1, Patrick Müller2, Fabian Schiedat3, Markus Schlömicher4, Justus Strauch4, Apostolos Chatzitomaris1, Harald H Klein1, Andreas Mügge3, Josef Köhrle5, Eddy Rijntjes5, Ina Lehmphul5.   

Abstract

BACKGROUND: Although hyperthyroidism predisposes to atrial fibrillation, previous trials have suggested decreased triiodothyronine (T3) concentrations to be associated with postoperative atrial fibrillation (POAF). Therapy with thyroid hormones (TH), however, did not reduce the risk of POAF. This study reevaluates the relation between thyroid hormone status, atrial electromechanical function and POAF.
METHODS: Thirty-nine patients with sinus rhythm and no history of atrial fibrillation or thyroid disease undergoing cardiac surgery were prospectively enrolled. Serum concentrations of thyrotropin, free (F) and total (T) thyroxine (T4) and T3, reverse (r)T3, 3-iodothyronamine (3-T1AM) and 3,5-diiodothyronine (3,5-T2) were measured preoperatively, complemented by evaluation of echocardiographic and electrophysiological parameters of cardiac function. Holter-ECG and telemetry were used to screen for POAF for 10 days following cardiac surgery.
RESULTS: Seven of 17 patients who developed POAF demonstrated nonthyroidal illness syndrome (NTIS; defined as low T3 and/or low T4 syndrome), compared to 2 of 22 (p < 0.05) patients who maintained sinus rhythm. In patients with POAF, serum FT3 concentrations were significantly decreased, but still within their reference ranges. 3,5-T2 concentrations directly correlated with rT3 concentrations and inversely correlated with FT3 concentrations. Furthermore, 3,5-T2 concentrations were significantly elevated in patients with NTIS and in subjects who eventually developed POAF. In multivariable logistic regression FT3, 3,5-T2, total atrial conduction time, left atrial volume index and Fas ligand were independent predictors of POAF.
CONCLUSION: This study confirms reduced FT3 concentrations in patients with POAF and is the first to report on elevated 3,5-T2 concentrations in cardiac NTIS. The pathogenesis of NTIS therefore seems to involve more differentiated allostatic mechanisms.

Entities:  

Keywords:  3,5-Diiodothyronine; Atrial fibrillation; Nonthyroidal illness syndrome; Reverse triiodothyronine; TACITUS; Thyroid hormone

Year:  2015        PMID: 26279999      PMCID: PMC4521060          DOI: 10.1159/000381543

Source DB:  PubMed          Journal:  Eur Thyroid J        ISSN: 2235-0640


  51 in total

1.  Total atrial conduction time assessed by tissue doppler imaging (PA-TDI Interval) to predict early recurrence of persistent atrial fibrillation after successful electrical cardioversion.

Authors:  Patrick Müller; Fabian Schiedat; Anna Bialek; Leif Bösche; Aydan Ewers; Kaffer Kara; Johannes W Dietrich; Andreas Mügge; Thomas Deneke
Journal:  J Cardiovasc Electrophysiol       Date:  2013-11-14

2.  The Thyroid Epidemiology, Audit, and Research Study (TEARS): morbidity in patients with endogenous subclinical hyperthyroidism.

Authors:  Thenmalar Vadiveloo; Peter T Donnan; Lynda Cochrane; Graham P Leese
Journal:  J Clin Endocrinol Metab       Date:  2011-02-23       Impact factor: 5.958

3.  Demonstration of in vivo metabolic effects of 3,5-di-iodothyronine.

Authors:  M Cimmino; F Mion; F Goglia; Y Minaire; A Géloën
Journal:  J Endocrinol       Date:  1996-05       Impact factor: 4.286

Review 4.  Thyroid hormone transporters in health and disease: advances in thyroid hormone deiodination.

Authors:  Josef Köhrle
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2007-06       Impact factor: 4.690

Review 5.  Thyroid disease and the heart.

Authors:  Irwin Klein; Sara Danzi
Journal:  Circulation       Date:  2007-10-09       Impact factor: 29.690

6.  Expression of thyroid hormone transporters during critical illness.

Authors:  Liese Mebis; Deborah Paletta; Yves Debaveye; Björn Ellger; Lies Langouche; André D'Hoore; Veerle M Darras; Theo J Visser; Greet Van den Berghe
Journal:  Eur J Endocrinol       Date:  2009-05-13       Impact factor: 6.664

7.  Heredity and lifestyle in the determination of between-subject variation in thyroid hormone levels in euthyroid men.

Authors:  Greet Roef; Youri Taes; Kaatje Toye; Stefan Goemaere; Tom Fiers; Alain Verstraete; Jean-Marc Kaufman
Journal:  Eur J Endocrinol       Date:  2013-10-21       Impact factor: 6.664

8.  Non-thyroidal illness syndrome and short-term survival in a hospitalised older population.

Authors:  Sara Tognini; Francesca Marchini; Angela Dardano; Antonio Polini; Marco Ferdeghini; Maido Castiglioni; Fabio Monzani
Journal:  Age Ageing       Date:  2009-11-16       Impact factor: 10.668

Review 9.  Mechanisms in endocrinology: Heart failure and thyroid dysfunction.

Authors:  Bernadette Biondi
Journal:  Eur J Endocrinol       Date:  2012-09-06       Impact factor: 6.664

10.  Subclinical hypothyroidism might increase the risk of transient atrial fibrillation after coronary artery bypass grafting.

Authors:  Young Joo Park; Ji Won Yoon; Kwang Il Kim; You Jin Lee; Kyung Won Kim; Sung Hee Choi; Soo Lim; Dong Ju Choi; Kay-Hyun Park; Joong Haeng Choh; Hak Chul Jang; Seong Yeon Kim; Bo Youn Cho; Cheong Lim
Journal:  Ann Thorac Surg       Date:  2009-06       Impact factor: 4.330

View more
  21 in total

Review 1.  Novel thyroid hormones.

Authors:  Riccardo Zucchi; Grazia Rutigliano; Federica Saponaro
Journal:  Endocrine       Date:  2019-07-20       Impact factor: 3.633

Review 2.  Relational Stability in the Expression of Normality, Variation, and Control of Thyroid Function.

Authors:  Rudolf Hoermann; John E M Midgley; Rolf Larisch; Johannes W Dietrich
Journal:  Front Endocrinol (Lausanne)       Date:  2016-11-07       Impact factor: 5.555

Review 3.  Thyroid Allostasis-Adaptive Responses of Thyrotropic Feedback Control to Conditions of Strain, Stress, and Developmental Programming.

Authors:  Apostolos Chatzitomaris; Rudolf Hoermann; John E Midgley; Steffen Hering; Aline Urban; Barbara Dietrich; Assjana Abood; Harald H Klein; Johannes W Dietrich
Journal:  Front Endocrinol (Lausanne)       Date:  2017-07-20       Impact factor: 5.555

Review 4.  Torpor: The Rise and Fall of 3-Monoiodothyronamine from Brain to Gut-From Gut to Brain?

Authors:  Hartmut H Glossmann; Oliver M D Lutz
Journal:  Front Endocrinol (Lausanne)       Date:  2017-05-31       Impact factor: 5.555

5.  Higher Prevalence of "Low T3 Syndrome" in Patients With Chronic Fatigue Syndrome: A Case-Control Study.

Authors:  Begoña Ruiz-Núñez; Rabab Tarasse; Emar F Vogelaar; D A Janneke Dijck-Brouwer; Frits A J Muskiet
Journal:  Front Endocrinol (Lausanne)       Date:  2018-03-20       Impact factor: 5.555

6.  Editorial: "Homeostasis and Allostasis of Thyroid Function".

Authors:  Johannes W Dietrich; John E M Midgley; Rudolf Hoermann
Journal:  Front Endocrinol (Lausanne)       Date:  2018-06-05       Impact factor: 5.555

7.  Calculated Parameters of Thyroid Homeostasis: Emerging Tools for Differential Diagnosis and Clinical Research.

Authors:  Johannes W Dietrich; Gabi Landgrafe-Mende; Evelin Wiora; Apostolos Chatzitomaris; Harald H Klein; John E M Midgley; Rudolf Hoermann
Journal:  Front Endocrinol (Lausanne)       Date:  2016-06-09       Impact factor: 5.555

Review 8.  Homeostatic Control of the Thyroid-Pituitary Axis: Perspectives for Diagnosis and Treatment.

Authors:  Rudolf Hoermann; John E M Midgley; Rolf Larisch; Johannes W Dietrich
Journal:  Front Endocrinol (Lausanne)       Date:  2015-11-20       Impact factor: 5.555

9.  3,5-Diiodo-l-Thyronine Increases Glucose Consumption in Cardiomyoblasts Without Affecting the Contractile Performance in Rat Heart.

Authors:  Ginevra Sacripanti; Nhat Minh Nguyen; Leonardo Lorenzini; Sabina Frascarelli; Alessandro Saba; Riccardo Zucchi; Sandra Ghelardoni
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-30       Impact factor: 5.555

Review 10.  Similarities and Differences in the Peripheral Actions of Thyroid Hormones and Their Metabolites.

Authors:  Ruy A Louzada; Denise P Carvalho
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-19       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.